Longya Hepatite, or Longya Hepatite Capsule, has no effect on the hepatitis B virus itself, but can be used as an adjunct in the treatment of chronic hepatitis B with abnormal liver function, and should be used in accordance with a doctor’s prescription.
The main ingredient of Longya Hepatite capsule is aralia aralia. It has the effect of lowering enzyme and protecting liver. It is suitable for the auxiliary treatment of chronic hepatitis and acute hepatitis with high transaminases. Therefore, Longya Hepatite Capsule has no effect on hepatitis B virus itself.
Adverse effects of Longya Hepatitis Capsules are not clear, allergy to the product is prohibited, allergic people should be cautious of using the drug. Taking 15 days of symptoms do not improve, or during the drug worsening, should promptly seek medical attention.
Hepatitis B antiviral treatment drugs need to be selected under the guidance of a doctor, such as entecavir, tenofovir, etc., not blindly self-medication, in order to avoid delaying the condition.